European Commission is not paying its share towards TB research, charity saysBMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2550 (Published 14 November 2008) Cite this as: BMJ 2008;337:a2550
- Peter Moszynski
The European Commission is failing to pay its fair share towards developing new vaccines, diagnostic tools, and treatments for tuberculosis, says the international healthcare charity Médecins Sans Frontières (MSF) in a new report.
The charity insists that more needs to be done to fight the disease in the face of a global epidemic that claims 1.7 million lives a year, and it is calling on the European Commission to increase its research funding fivefold.
“Because the tests and drugs we use today aren’t anything like effective enough, MSF teams responding to the epidemic in Africa and Asia are faced with an almost …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial